FI
ANAB icon

Fosun International’s AnaptysBio ANAB Stock Holding History

Fosun International’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14,696
Closed -$801K – 235
2019
Q2 		$801K Sell
14,696
-16,000
-52% -$1.15M 0.05% 190
2019
Q1 		$2.12M Buy
30,696
+9,100
+42% +$628K 0.13% 98
2018
Q4 		$1.33M Buy
+21,596
New +$1.61M 0.08% 115

Other funds holding ANAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fosun International's ANAB Position: Q3 2019 in Review

Fosun International sold out of AnaptysBio (ANAB) in Q3 2019, closing a stake of 14,696 shares — an estimated $801K sold.

Fosun International first reported a position in ANAB in Q4 2018 and held it in 3 quarters. The position peaked at $2.12M in Q1 2019. 119 funds tracked by Wall St. Rank hold ANAB as of Q3 2019.

  • Fosun International reported no remaining AnaptysBio position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 14,696 AnaptysBio shares in Q3 2019, an estimated $801K.
  • Fosun International first reported a position in AnaptysBio in Q4 2018 and held it in 3 quarters.
  • Fosun International's AnaptysBio position peaked at $2.12M in Q1 2019.
  • 119 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.